Sun Pharmaceutical Industries per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹50.40₹47.80₹45.60₹39.90₹35.30
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹50.40₹47.80₹45.60₹39.90₹35.30
₹348.31₹348.31₹301.32₹265.36₹233.38
₹249.70₹243.66₹219.38₹202.13₹182.91
—₹51.76₹58.71₹50.58₹20.67
₹36.72₹36.72₹49.83₹41.40₹11.98
—₹16.41₹15.09₹12.09₹10.50
239.9239.9239.7239.9239.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SUNPHARMA₹1,757.50

Sun Pharmaceutical Industries Ltd.

· Pharma & Health
₹ CrorePeersCIPLADRREDDYLUPINAPOLLOHOSPMAXHEALTHDIVISLABTORNTPHARMZYDUSLIFEMcap ₹4.22L Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS35.3039.9045.6047.8050.40
Diluted EPS35.3039.9045.6047.8050.40
Book Value per Share233.38265.36301.32348.31348.31
Revenue per Share182.91202.13219.38243.66249.70
Cash Flow per Share20.6750.5858.7151.76—
Free Cash Flow per Share11.9841.4049.8336.7236.72
Dividends per Share10.5012.0915.0916.41—
Shares Outstanding (cr)239.9239.9239.7239.9239.9
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 199%.